The caller alleged a variance between the inratio inr result in comparison to the lab/poc inr result.The results were as follows; (b)(6) unsure if lab or poc=4.8, (b)(6) inratio=4.0, (b)(6) inratio=1.4, (b)(6) lab=2.7.Patient self tester's therapeutic range: 2.0-3.0.The patient self tester went to the physician's office on (b)(6) and had his inr tested, inr=4.8.Wife was unsure if the result was obtained through a poc meter or a laboratory method.No dosage changes were made because the physician did not agree with the result.On (b)(6) patient tested on his monitor with result of inratio inr=4.0.This result was reported to physician and dosage was changed.Testing was done on (b)(6) with inratio=1.4; physician had patient self tester increase dosage however wife does not remember how much of an increase.On (b)(6) the patient self tester attempted to retest again and received 2 error messages (for not enough sample); no dosage changes were made.On (b)(6) a lab test was performed with an inr=2.7.Using the venous blood testing was done on the inratio monitor with qc2h error message.
|
It is indicated that the product is not returning for evaluation.Therefore, a review of the in-house testing history was performed.In-house testing on strip lot 369157a met release criteria.The product performed as expected.A review of the manufacturing records for lot# 369157a did not uncover any non-conformances.The lot met release specifications.Root cause could not be determined from the information provided by the customer.Based on the information available, there is no indication of a product deficiency.No corrective action is required at this time.
|